Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
192 hedge funds and large institutions have $3.48B invested in Immunomedics Inc in 2018 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 79 increasing their positions, 51 reducing their positions, and 19 closing their positions.
132% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 19
90% more capital invested
Capital invested by funds: $1.83B → $3.48B (+$1.65B)
55% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 51
14% more funds holding
Funds holding: 168 → 192 (+24)
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
36% less call options, than puts
Call options by funds: $118M | Put options by funds: $184M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$113M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$62.7M |
| 3 |
BlackRock
New York
|
+$44.1M |
| 4 |
Alkeon Capital Management
New York
|
+$37.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$40.5M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$22.1M |
| 3 |
State Street
Boston,
Massachusetts
|
-$20M |
| 4 |
O
OrbiMed
New York
|
-$15.4M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$12.8M |
IMMU Hedge Fund Activity: Q2 2018 in Review
192 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2018, worth a combined $3.48B — up 90% from $1.83B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new IMMU positions and 19 closed out — a net gain of 25 holders — while 79 added to existing stakes and 51 trimmed.
The largest buyer was Vanguard Group, adding an estimated $113M. The largest seller was NEA Management Company, exiting entirely with an estimated $40.5M sold.
- 192 institutional investors held Immunomedics Inc (IMMU) as of Q2 2018, up from 168 in Q1 2018.
- Funds reported $3.48B of Immunomedics Inc stock for Q2 2018, up 90% quarter-over-quarter.
- 44 funds opened new Immunomedics Inc positions in Q2 2018 and 19 closed out, a net change of +25 holders.
- The largest Immunomedics Inc buyer in Q2 2018 was Vanguard Group, an estimated $113M added.
- The largest Immunomedics Inc seller in Q2 2018 was NEA Management Company, an estimated $40.5M sold.
Based on aggregated 13F filings for Q2 2018.